MX2009005444A - Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. - Google Patents

Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Info

Publication number
MX2009005444A
MX2009005444A MX2009005444A MX2009005444A MX2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A MX 2009005444 A MX2009005444 A MX 2009005444A
Authority
MX
Mexico
Prior art keywords
steroidal
delivery system
hydrophilic drug
vinyl acetate
polymer
Prior art date
Application number
MX2009005444A
Other languages
English (en)
Spanish (es)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005444A publication Critical patent/MX2009005444A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009005444A 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. MX2009005444A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062626 WO2008062008A1 (en) 2006-11-22 2007-11-21 Delivery system for a non-steroidal non-ionized hydrophilic drug

Publications (1)

Publication Number Publication Date
MX2009005444A true MX2009005444A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Country Status (6)

Country Link
US (2) US20100203104A1 (OSRAM)
EP (2) EP2094348A1 (OSRAM)
JP (2) JP2010510287A (OSRAM)
CA (2) CA2670454A1 (OSRAM)
MX (2) MX2009005444A (OSRAM)
WO (2) WO2008062009A1 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
US7858110B2 (en) * 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
JP2009542788A (ja) * 2006-07-12 2009-12-03 コントロールド・セラピューティクス（スコットランド）・リミテッド クリンダマイシンの塩酸塩を有する薬剤デリバリーポリマー
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2094348A1 (en) * 2006-11-22 2009-09-02 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
US9078900B2 (en) * 2008-09-30 2015-07-14 Braeburn Pharmaceuticals Bvba Sprl Implantable device for the delivery of risperidone and methods of use thereof
CA2792484C (en) * 2009-03-12 2017-10-31 Delpor, Inc. Implantable device for long-term delivery of drugs
SI2547332T1 (sl) 2010-03-16 2019-01-31 Titan Pharmaceuticals, Inc. Heterogeni vsadljivi pripomočki za dovajanje zdravila
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
CA3087410A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
JP2021524841A (ja) 2018-05-24 2021-09-16 セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー 高分子薬剤化合物の持続放出用の埋め込み型デバイス
US12472148B2 (en) 2021-04-26 2025-11-18 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
ATE207736T1 (de) * 1995-07-04 2001-11-15 Akzo Nobel Nv Ringförmige vorrichtung
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
CA2442281C (en) * 2001-03-27 2010-06-08 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
CN100340395C (zh) * 2002-08-30 2007-10-03 阿尔扎公司 多层层压背衬结构体
JP5306599B2 (ja) * 2004-01-12 2013-10-02 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 長期間送達製剤
BRPI0509146B8 (pt) * 2004-03-24 2021-05-25 Merck Sharp & Dohme sistema de liberação de droga, método de fabricação do mesmo, e, uso do sistema de liberação de droga
AU2005304435B8 (en) * 2004-11-10 2011-06-23 Tolmar Therapeutics, Inc. A stabilized polymeric delivery system
EP2094348A1 (en) * 2006-11-22 2009-09-02 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug
US20100129425A1 (en) * 2006-11-22 2010-05-27 N.V. Organon Vaginal delivery system for mirtazapine

Also Published As

Publication number Publication date
MX2009005445A (es) 2009-06-02
JP2010510287A (ja) 2010-04-02
WO2008062009A1 (en) 2008-05-29
JP2010510286A (ja) 2010-04-02
CA2670454A1 (en) 2008-05-29
WO2008062008A1 (en) 2008-05-29
US20100203104A1 (en) 2010-08-12
CA2670157A1 (en) 2008-05-29
EP2094270A1 (en) 2009-09-02
US20100104619A1 (en) 2010-04-29
EP2094348A1 (en) 2009-09-02

Similar Documents

Publication Publication Date Title
MX2009005444A (es) Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
JP2010510286A5 (OSRAM)
NZ628828A (en) Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
WO2004112748A3 (en) Rate controlled release of a pharmaceutical agent in a biodegradable device
WO2008129106A3 (es) Nanopartículas que comprenden una ciclodextrina y una molécula biológicamente activa y sus aplicaciones
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2008100375A3 (en) Polymer-based films and drug delivery systems made therefrom
TW200616589A (en) Transdermal delivery of drugs based on crystal size
MX2019003443A (es) Peliculas permeables con propiedades de barrera microbiana.
SI2905014T1 (en) An intrauterine delivery system for contraception
MXPA05013138A (es) Composiciones adhesivas, articulos que incorporan las mismas y metodos de manufactura de las mismas.
WO2008153611A3 (en) Sustained delivery formulations of risperidone compounds
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
ATE459345T1 (de) Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
WO2012016287A3 (en) Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
WO2007131193A3 (en) Main chain acid-degradable polymers for the delivery of bioactive materials
GB2544216A (en) Anti-adherent composition
WO2004112713A3 (en) Drug polymer complexes
WO2009148580A3 (en) Controlled release copolymer formulation with improved release kinetics
IL280267B1 (en) A preparation for dermal administration of an active substance and a bandage that includes it
MX2010005013A (es) Composiciones intranasales.
WO2006013374A3 (en) Polymeric medical devices for the control of microbial infections

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal